{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T03:52:09Z","timestamp":1785037929490,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.bbrc.2004.05.142","type":"journal-article","created":{"date-parts":[[2004,6,8]],"date-time":"2004-06-08T16:40:17Z","timestamp":1086712817000},"page":"90-94","source":"Crossref","is-referenced-by-count":11,"title":["Inhibition of the human organic anion transporter 1 by the caffeine metabolite 1-methylxanthine"],"prefix":"10.1016","volume":"320","author":[{"given":"Jens","family":"Rengelshausen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Lindenmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Cihlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Walter-Sack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter Emil","family":"Haefeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2004.05.142_BIB1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00003495-199549010-00004","article-title":"Pharmacological rationale for the clinical use of caffeine","volume":"49","author":"Sawynok","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.bbrc.2004.05.142_BIB2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/clpt.1993.63","article-title":"The use of caffeine for enzyme assays: a critical appraisal","volume":"53","author":"Kalow","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2125.2003.01725.x","article-title":"Interaction of ibuprofen and probenecid with phenotyping procedures using caffeine as probe drug","volume":"55","author":"Vrtic","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.pharmtox.44.101802.121856","article-title":"Transporters and renal drug elimination","volume":"44","author":"Lee","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000025863","article-title":"Cloning of a human renal p-aminohippurate transporter, hROAT1","volume":"21","author":"Reid","year":"1998","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB6","doi-asserted-by":"crossref","first-page":"F122","DOI":"10.1152\/ajprenal.1999.276.1.F122","article-title":"Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney","volume":"276","author":"Hosoyamada","year":"1999","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1006\/bbrc.1998.9978","article-title":"Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3)","volume":"255","author":"Race","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB8","first-page":"F295","article-title":"Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C","volume":"276","author":"Lu","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1124\/mol.56.3.570","article-title":"The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1","volume":"56","author":"Cihlar","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1681\/ASN.V134866","article-title":"Gene expression levels and immunolocalization of organic ion transporters in the human kidney","volume":"13","author":"Motohashi","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB11","doi-asserted-by":"crossref","first-page":"C1019","DOI":"10.1152\/ajpcell.2000.278.5.C1019","article-title":"Structure, function, and genomic organization of human Na(+)-dependent high-affinity dicarboxylate transporter","volume":"278","author":"Wang","year":"2000","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB12","first-page":"F239","article-title":"Monovalent cation and ouabain effects on PAH uptake by rabbit kidney slices","volume":"232","author":"Podevin","year":"1977","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1124\/dmd.30.1.13","article-title":"The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies","volume":"30","author":"Hill","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1254\/jjp.88.69","article-title":"Human organic anion transporters mediate the transport of tetracycline","volume":"88","author":"Babu","year":"2002","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB15","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1124\/jpet.300.3.918","article-title":"Human organic anion transporters and human organic cation transporters mediate renal antiviral transport","volume":"300","author":"Takeda","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB16","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1124\/jpet.102.037580","article-title":"Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs","volume":"303","author":"Khamdang","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB17","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/jpet.102.034330","article-title":"Characterization of methotrexate transport and its drug interactions with human organic anion transporters","volume":"302","author":"Takeda","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB18","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/bmj.1.6120.1097","article-title":"Prolongation and enhancement of serum methotrexate concentrations by probenecid","volume":"1","author":"Aherne","year":"1978","journal-title":"Br. Med. J."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/abio.2000.4633","article-title":"Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporter 1","volume":"283","author":"Cihlar","year":"2000","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1681\/ASN.V113383","article-title":"Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1","volume":"11","author":"Ho","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1124\/dmd.32.4.424","article-title":"Expression studies and functional characterization of renal human organic anion transporter 1 isoforms","volume":"32","author":"Bahn","year":"2004","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB22","first-page":"114","article-title":"Molecular physiology of renal p-aminohippurate secretion","volume":"16","author":"Burckhardt","year":"2001","journal-title":"News Physiol. Sci."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB23","doi-asserted-by":"crossref","first-page":"F503","DOI":"10.1152\/ajprenal.00290.2002","article-title":"Transport of cimetidine by flounder and human renal organic anion transporter 1","volume":"284","author":"Burckhardt","year":"2003","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000074539","article-title":"Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux","volume":"13","author":"Bakhiya","year":"2003","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB25","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/mol.59.5.1277","article-title":"Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney","volume":"59","author":"Cha","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB26","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1124\/jpet.301.3.797","article-title":"Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors","volume":"301","author":"Enomoto","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1254\/jphs.94.297","article-title":"Human organic anion transporter 4 is a renal apical organic anion\/dicarboxylate exchanger in the proximal tubules","volume":"94","author":"Ekaratanawong","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2004.05.142_BIB28","first-page":"2072","article-title":"The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5mg","volume":"22","author":"Kremer","year":"1995","journal-title":"J. Rheumatol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X04011532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X04011532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:49:19Z","timestamp":1624409359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X04011532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0006291X04011532"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2004.05.142","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}